These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 9345392

  • 1. Early treatment trials with interferon beta in multiple sclerosis.
    Panitch HS.
    Mult Scler; 1995; 1 Suppl 1():S17-21. PubMed ID: 9345392
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dose and frequency of interferon treatment matter--INCOMIN and OPTIMS.
    Durelli L.
    J Neurol; 2003 Dec; 250 Suppl 4():IV9-IV14. PubMed ID: 14712396
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interferon alpha treatment of relapsing-remitting multiple sclerosis: long-term study of the correlations between clinical and magnetic resonance imaging results and effects on the immune function.
    Durelli L, Bongioanni MR, Cavallo R, Ferrero B, Ferri R, Verdun E, Bradac GB, Riva A, Geuna M, Bergamini L.
    Mult Scler; 1995 Dec; 1 Suppl 1():S32-7. PubMed ID: 9345396
    [Abstract] [Full Text] [Related]

  • 9. High-dose, frequently administered interferon beta therapy for relapsing-remitting multiple sclerosis must be maintained over the long term: the interferon beta dose-reduction study.
    Barbero P, Verdun E, Bergui M, Pipieri A, Clerico M, Cucci A, Ricci A, Bergamasco B, Durelli L.
    J Neurol Sci; 2004 Jul 15; 222(1-2):13-9. PubMed ID: 15240190
    [Abstract] [Full Text] [Related]

  • 10. Interferon beta 1a.
    Pozzilli C, Koudriavtseva T.
    Baillieres Clin Neurol; 1997 Oct 15; 6(3):481-93. PubMed ID: 10101585
    [Abstract] [Full Text] [Related]

  • 11. Role of steroids and immunosuppression and effects of interferon beta-1b in multiple sclerosis.
    Goodkin DE.
    West J Med; 1994 Sep 15; 161(3):292-8. PubMed ID: 7975569
    [Abstract] [Full Text] [Related]

  • 12. Combination therapy with interferon beta-1a and doxycycline in multiple sclerosis: an open-label trial.
    Minagar A, Alexander JS, Schwendimann RN, Kelley RE, Gonzalez-Toledo E, Jimenez JJ, Mauro L, Jy W, Smith SJ.
    Arch Neurol; 2008 Feb 15; 65(2):199-204. PubMed ID: 18071030
    [Abstract] [Full Text] [Related]

  • 13. Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.
    Hurwitz BJ, Jeffery D, Arnason B, Bigley K, Coyle P, Goodin D, Kaba S, Kirzinger S, Lynch S, Mandler R, Mikol D, Rammohan K, Sater R, Sriram S, Thrower B, Boateng F, Jakobs P, Wash MB, Bogumil T.
    Clin Ther; 2008 Jun 15; 30(6):1102-12. PubMed ID: 18640466
    [Abstract] [Full Text] [Related]

  • 14. Recombinant human interferon beta in the treatment of relapsing-remitting and secondary progressive multiple sclerosis.
    Sandberg-Wollheim M, Hommes OR, Hughes RA, Paty DW, Abdul-Ahad AK.
    Mult Scler; 1995 Jun 15; 1 Suppl 1():S48-50. PubMed ID: 9345399
    [Abstract] [Full Text] [Related]

  • 15. [Natural interferon-beta in the treatment of relapsing-remitting multiple sclerosis: a multicenter, randomized, MRI-based, phase II clinical trial].
    Fernández O, Antigüedad A, Arbizu T, Burgués S, Capdevila A, de Castro P, Correa de Sá JC, García-Merino JA, Izquierdo G, Magalhaes A, Montalbán X, Zarranz JJ.
    Rev Neurol; 1995 Jun 15; 29(12):1093-9. PubMed ID: 10652728
    [Abstract] [Full Text] [Related]

  • 16. Treatment of multiple sclerosis with interferon beta 1b.
    Dhib-Jalbut S, McFarland HF.
    Baillieres Clin Neurol; 1997 Oct 15; 6(3):467-80. PubMed ID: 10101584
    [Abstract] [Full Text] [Related]

  • 17. Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon beta.
    Comi G.
    Clin Ther; 2009 Jun 15; 31(6):1142-57. PubMed ID: 19695384
    [Abstract] [Full Text] [Related]

  • 18. Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience.
    Pozzilli C, Prosperini L, Sbardella E, De Giglio L, Onesti E, Tomassini V.
    Neurol Sci; 2005 Dec 15; 26 Suppl 4():S174-8. PubMed ID: 16388353
    [Abstract] [Full Text] [Related]

  • 19. Early treatment.
    Comi G.
    Neurol Sci; 2006 Mar 15; 27 Suppl 1():S8-12. PubMed ID: 16708191
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.